APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vandetanib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vandetanib Tablets Market Analysis and Forecast 2026-2032

Report ID 174045100227 December 2025199 pages

Choose your research edition.

Industry ResearchVandetanib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Vandetanib Tablets Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Vandetanib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vandetanib Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Vandetanib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vandetanib Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vandetanib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vandetanib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vandetanib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vandetanib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vandetanib Tablets include Lucius Pharma, AstraZeneca and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vandetanib Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vandetanib Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Vandetanib Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vandetanib Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vandetanib Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vandetanib Tablets sales, projected growth trends, production technology, application and end-user industry.

Vandetanib Tablets Segment by Company

Lucius Pharma

AstraZeneca

Sanofi

Vandetanib Tablets Segment by Type

100mg per Tablet

300mg per Tablet

Vandetanib Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Vandetanib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vandetanib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vandetanib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vandetanib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vandetanib Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vandetanib Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vandetanib Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vandetanib Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg per Tablet Major Manufacturers Table 3. 300mg per Tablet Major Manufacturers Table 4. Global Vandetanib Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Other Major Manufacturers Table 8. Vandetanib Tablets Industry Trends Table 9. Vandetanib Tablets Industry Drivers Table 10. Vandetanib Tablets Industry Opportunities and Challenges Table 11. Vandetanib Tablets Industry Restraints Table 12. Global Vandetanib Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Vandetanib Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Vandetanib Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Vandetanib Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Vandetanib Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Vandetanib Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Vandetanib Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Vandetanib Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Vandetanib Tablets Sales Market Share by Region (2021-2026) Table 21. Global Vandetanib Tablets Sales Market Share by Region (2027-2032) Table 22. Global Vandetanib Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Vandetanib Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Vandetanib Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Vandetanib Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Vandetanib Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Vandetanib Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Vandetanib Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Vandetanib Tablets Manufacturers, Product Type & Application Table 30. Global Vandetanib Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Vandetanib Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Vandetanib Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Vandetanib Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Vandetanib Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Vandetanib Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Vandetanib Tablets Sales Market Share by Type (2021-2026) Table 42. Global Vandetanib Tablets Sales Market Share by Type (2027-2032) Table 43. Global Vandetanib Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Vandetanib Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Vandetanib Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Vandetanib Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Vandetanib Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Vandetanib Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Vandetanib Tablets Sales Market Share by Application (2021-2026) Table 54. Global Vandetanib Tablets Sales Market Share by Application (2027-2032) Table 55. Global Vandetanib Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vandetanib Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Lucius Pharma Company Information Table 58. Lucius Pharma Business Overview Table 59. Lucius Pharma Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Lucius Pharma Vandetanib Tablets Product Portfolio Table 61. Lucius Pharma Recent Development Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. AstraZeneca Vandetanib Tablets Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sanofi Vandetanib Tablets Product Portfolio Table 71. Sanofi Recent Development Table 72. North America Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 75. North America Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 76. North America Vandetanib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Vandetanib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 81. North America Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 82. North America Vandetanib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Vandetanib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Vandetanib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Vandetanib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 89. North America Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 90. North America Vandetanib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Vandetanib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 93. Canada Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 94. Mexico Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 95. Europe Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 98. Europe Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 99. Europe Vandetanib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Vandetanib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 104. Europe Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 105. Europe Vandetanib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Vandetanib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Vandetanib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Vandetanib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 112. Europe Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 113. Europe Vandetanib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Vandetanib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 116. France Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 117. U.K. Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 118. Italy Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 119. Russia Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 120. Spain Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 123. Sweden Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 124. Poland Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 125. China Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 126. China Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 127. China Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 128. China Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 129. China Vandetanib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Vandetanib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 132. China Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 133. China Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 134. China Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 135. China Vandetanib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Vandetanib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 140. Asia Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 141. Asia Vandetanib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Vandetanib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 146. Asia Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 147. Asia Vandetanib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Vandetanib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Vandetanib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Vandetanib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 154. Asia Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 155. Asia Vandetanib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Vandetanib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 158. South Korea Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 159. India Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 160. Australia Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Vandetanib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Vandetanib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Vandetanib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Vandetanib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Vandetanib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Vandetanib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Vandetanib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Vandetanib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Vandetanib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Vandetanib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Vandetanib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Vandetanib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 184. Argentina Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 185. Chile Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 186. Colombia Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 187. Peru Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 189. Israel Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 190. UAE Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 191. Turkey Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 192. Iran Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 193. Egypt Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Vandetanib Tablets Distributors List Table 197. Vandetanib Tablets Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Vandetanib Tablets Image Figure 2. Global Vandetanib Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vandetanib Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg per Tablet Image Figure 5. 300mg per Tablet Image Figure 6. Global Vandetanib Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Vandetanib Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Retail Pharmacies Image Figure 10. Other Image Figure 11. Global Vandetanib Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Vandetanib Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Vandetanib Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Vandetanib Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Vandetanib Tablets Sales (2021-2032) & (K Units) Figure 17. Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Vandetanib Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Vandetanib Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Vandetanib Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Vandetanib Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Vandetanib Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Vandetanib Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Vandetanib Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Vandetanib Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Vandetanib Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Vandetanib Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Vandetanib Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Vandetanib Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Vandetanib Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Vandetanib Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Vandetanib Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Vandetanib Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Vandetanib Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Vandetanib Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Vandetanib Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Vandetanib Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Vandetanib Tablets Revenue Share by Type (2021-2032) Figure 40. North America Vandetanib Tablets Sales Share by Type (2021-2032) Figure 41. North America Vandetanib Tablets Revenue Share by Application (2021-2032) Figure 42. North America Vandetanib Tablets Sales Share by Application (2021-2032) Figure 43. North America Vandetanib Tablets Revenue Share by Country (2021-2032) Figure 44. North America Vandetanib Tablets Sales Share by Country (2021-2032) Figure 45. Europe Vandetanib Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Vandetanib Tablets Sales Share by Type (2021-2032) Figure 47. Europe Vandetanib Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Vandetanib Tablets Sales Share by Application (2021-2032) Figure 49. Europe Vandetanib Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Vandetanib Tablets Sales Share by Country (2021-2032) Figure 51. China Vandetanib Tablets Revenue Share by Type (2021-2032) Figure 52. China Vandetanib Tablets Sales Share by Type (2021-2032) Figure 53. China Vandetanib Tablets Revenue Share by Application (2021-2032) Figure 54. China Vandetanib Tablets Sales Share by Application (2021-2032) Figure 55. Asia Vandetanib Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Vandetanib Tablets Sales Share by Type (2021-2032) Figure 57. Asia Vandetanib Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Vandetanib Tablets Sales Share by Application (2021-2032) Figure 59. Asia Vandetanib Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Vandetanib Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Vandetanib Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Vandetanib Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Vandetanib Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Vandetanib Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Vandetanib Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Vandetanib Tablets Sales Share by Country (2021-2032) Figure 67. Vandetanib Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Vandetanib Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 300mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Lucius Pharma
  • AstraZeneca
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vandetanib Tablets Market by Type
  3. 1.2.1 Global Vandetanib Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg per Tablet
  5. 1.2.3 300mg per Tablet
  6. 1.3 Vandetanib Tablets Market by Application
  7. 1.3.1 Global Vandetanib Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Vandetanib Tablets Market Dynamics
  1. 2.1 Vandetanib Tablets Industry Trends
  2. 2.2 Vandetanib Tablets Industry Drivers
  3. 2.3 Vandetanib Tablets Industry Opportunities and Challenges
  4. 2.4 Vandetanib Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vandetanib Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vandetanib Tablets Revenue by Region
  3. 3.2.1 Global Vandetanib Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vandetanib Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Vandetanib Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Vandetanib Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vandetanib Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vandetanib Tablets Sales by Region
  9. 3.4.1 Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vandetanib Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Vandetanib Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Vandetanib Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vandetanib Tablets Revenue by Manufacturers
  2. 4.1.1 Global Vandetanib Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vandetanib Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vandetanib Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vandetanib Tablets Sales by Manufacturers
  6. 4.2.1 Global Vandetanib Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vandetanib Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vandetanib Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vandetanib Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vandetanib Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vandetanib Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vandetanib Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Vandetanib Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vandetanib Tablets Market CR5 and HHI
  16. 4.8.2 2025 Vandetanib Tablets Tier 1, Tier 2, and Tier 3
5 Vandetanib Tablets Market by Type
  1. 5.1 Global Vandetanib Tablets Revenue by Type
  2. 5.1.1 Global Vandetanib Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vandetanib Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vandetanib Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vandetanib Tablets Sales by Type
  6. 5.2.1 Global Vandetanib Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vandetanib Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Vandetanib Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vandetanib Tablets Price by Type
6 Vandetanib Tablets Market by Application
  1. 6.1 Global Vandetanib Tablets Revenue by Application
  2. 6.1.1 Global Vandetanib Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vandetanib Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vandetanib Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vandetanib Tablets Sales by Application
  6. 6.2.1 Global Vandetanib Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vandetanib Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Vandetanib Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vandetanib Tablets Price by Application
7 Company Profiles
  1. 7.1 Lucius Pharma
  2. 7.1.1 Lucius Pharma Company Information
  3. 7.1.2 Lucius Pharma Business Overview
  4. 7.1.3 Lucius Pharma Vandetanib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lucius Pharma Vandetanib Tablets Product Portfolio
  6. 7.1.5 Lucius Pharma Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Vandetanib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Vandetanib Tablets Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Vandetanib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Vandetanib Tablets Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Vandetanib Tablets Market Size by Type
  2. 8.1.1 North America Vandetanib Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Vandetanib Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Vandetanib Tablets Price by Type (2021-2032)
  5. 8.2 North America Vandetanib Tablets Market Size by Application
  6. 8.2.1 North America Vandetanib Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Vandetanib Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Vandetanib Tablets Price by Application (2021-2032)
  9. 8.3 North America Vandetanib Tablets Market Size by Country
  10. 8.3.1 North America Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vandetanib Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vandetanib Tablets Market Size by Type
  2. 9.1.1 Europe Vandetanib Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vandetanib Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Vandetanib Tablets Price by Type (2021-2032)
  5. 9.2 Europe Vandetanib Tablets Market Size by Application
  6. 9.2.1 Europe Vandetanib Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vandetanib Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Vandetanib Tablets Price by Application (2021-2032)
  9. 9.3 Europe Vandetanib Tablets Market Size by Country
  10. 9.3.1 Europe Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vandetanib Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vandetanib Tablets Market Size by Type
  2. 10.1.1 China Vandetanib Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Vandetanib Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Vandetanib Tablets Price by Type (2021-2032)
  5. 10.2 China Vandetanib Tablets Market Size by Application
  6. 10.2.1 China Vandetanib Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Vandetanib Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Vandetanib Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vandetanib Tablets Market Size by Type
  2. 11.1.1 Asia Vandetanib Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vandetanib Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Vandetanib Tablets Price by Type (2021-2032)
  5. 11.2 Asia Vandetanib Tablets Market Size by Application
  6. 11.2.1 Asia Vandetanib Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vandetanib Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Vandetanib Tablets Price by Application (2021-2032)
  9. 11.3 Asia Vandetanib Tablets Market Size by Country
  10. 11.3.1 Asia Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vandetanib Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vandetanib Tablets Market Size by Type
  2. 12.1.1 SAMEA Vandetanib Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vandetanib Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vandetanib Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Vandetanib Tablets Market Size by Application
  6. 12.2.1 SAMEA Vandetanib Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vandetanib Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vandetanib Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Vandetanib Tablets Market Size by Country
  10. 12.3.1 SAMEA Vandetanib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vandetanib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vandetanib Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vandetanib Tablets Value Chain Analysis
  2. 13.1.1 Vandetanib Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vandetanib Tablets Production Mode & Process
  6. 13.2 Vandetanib Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vandetanib Tablets Distributors
  9. 13.2.3 Vandetanib Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst